Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT)
ID: 353486Type: Posted
Overview

Buyer

Advanced Research Projects Agency for Health (HHS-ARPAH)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353486

Additional Information

https://sam.gov/opp/0cc6823a822e4416ae2b12d67b548ea5/view
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 10, 2024, 12:00 AM UTC
  4. 4
    Due Aug 27, 2024, 12:00 AM UTC
Description

The Advanced Research Projects Agency for Health (ARPA-H) is offering a funding opportunity for the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) Program, aimed at advancing innovative solutions in regenerative medicine. This initiative anticipates multiple awards and seeks proposals that align with the program's objectives, with a focus on developing nanotechnology-based tissue solutions. The program is significant for its potential to enhance healthcare outcomes through cutting-edge research and development in science and technology. Interested applicants should note that the proposal due date is August 20, 2024, at 9:00 AM ET, and can contact the PRINT Program Team at PRINT@ARPA-H.gov for further information. Additional details can be found on the SAM.gov posting.

Point(s) of Contact
PRINT@ARPA-H.gov
Files
No associated files provided.
Similar Opportunities
Alzheimer’s Research Program Transforming Research Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Research Award to support innovative research aimed at reducing the risk of Alzheimer's disease and related dementias (AD/ADRD). This grant opportunity encourages diverse applicants, including for-profit, non-profit, and academic institutions, and emphasizes the necessity of community collaboration, particularly for clinical research projects. With an estimated total program funding of $4 million, the program anticipates awarding approximately four grants, each providing up to $1 million over a maximum of three years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due by August 29, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
Biological Technologies
DARPA - Biological Technologies Office
The Defense Advanced Research Projects Agency (DARPA) is inviting proposals for its Biological Technologies initiative under the Broad Agency Announcement (BAA) HR001124S0034. This opportunity seeks innovative research ideas that address topics not currently covered by existing BTO programs, focusing on advancements in biological technologies, machine learning applications in biology, human performance optimization, and biosecurity technologies. The proposals will be evaluated based on scientific merit, relevance to national security, and cost realism, with a submission period running from September 11, 2024, to September 10, 2025. Interested applicants can reach out to the BAA Coordinator at BTOBAA2024@darpa.mil for further information and are encouraged to review the detailed submission guidelines available on SAM.gov.
SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS)
Advanced Research Projects Agency Energy
The Advanced Research Projects Agency - Energy (ARPA-E) is offering a funding opportunity titled "SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS)" aimed at supporting innovative energy research and development projects. This grant program encourages the submission of transformative ideas that can lead to significant advancements in energy technologies, with a focus on projects that have the potential to create new learning curves and disrupt existing markets. With an estimated total program funding of $10 million, individual awards can range from $0 to $500,000, and the application process requires registration and submission through the ARPA-E eXCHANGE platform. Interested applicants should note that the application deadline is September 30, 2029, and for further inquiries, they can contact ARPA-E at arpa-e-co@hq.doe.gov.
Airman Readiness Medical Research (ARMR) Hybrid BAA
Air Force -- Research Lab
The Air Force Research Laboratory (AFRL) is soliciting proposals for the Airman Readiness Medical Research (ARMR) program through a Hybrid Broad Agency Announcement (BAA) designated FA8650-20-S-6008. The primary objectives of this initiative are to conduct medical research aimed at optimizing the health and performance of Airmen, focusing on ensuring medical availability and understanding the effects of various operational environments on Airman well-being. This program is critical for enhancing the operational readiness of military personnel, particularly in high-demand mission scenarios, with key research areas including aeromedical evacuation, cognitive performance, and exposure health. The total funding available for this program is estimated at $480 million, with individual awards ranging from $50,000 to $49 million. Interested parties are encouraged to submit white papers by May 1, 2025, and can direct inquiries to Amber A. Taylor at amber.taylor.9@us.af.mil.
Ensuring Research Integrity - Program Development and Evaluation Program (PDE)
Office of the Assistant Secretary for Health
The Office of the Assistant Secretary for Health is forecasting a federal grant opportunity titled "Ensuring Research Integrity - Program Development and Evaluation Program (PDE)." This initiative aims to fund projects that develop and implement innovative approaches and tools to promote research integrity and prevent misconduct, including educational resources, risk assessment tools, and intervention programs. The importance of this funding lies in its potential to enhance ethical research practices and foster a culture of integrity within research environments. The estimated total program funding is $150,000, with individual awards ranging from $50,000 to $75,000, and applications are expected to be submitted electronically by April 10, 2025. For further inquiries, interested parties can contact Armineh Ghazarian at Armineh.Ghazarian@hhs.gov or by phone at 240-453-8200.
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting innovative technology projects that advance biomedical research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that demonstrate proof-of-concept and the development of working prototypes without integrating clinical trials. This initiative is crucial for fostering technological advancements that enhance understanding of biological processes, with no budget cap and a maximum project duration of five years. Interested applicants can find more information and application guidelines at NIH Grants, with proposals due by January 7, 2028.
Ensuring Research Integrity - Research on Research Integrity (RRI)
Office of the Assistant Secretary for Health
The Office of the Assistant Secretary for Health is forecasting a federal grant opportunity titled "Ensuring Research Integrity - Research on Research Integrity (RRI)." This initiative aims to enhance the quality and integrity of biomedical and behavioral research by funding projects that investigate the root causes of research misconduct and the factors that promote research integrity. The grant will support social and behavioral research focusing on various aspects, including institutional culture, policy effectiveness, and reporting mechanisms, with a total estimated funding of $500,000 available for two awards, each ranging from $150,000 to $250,000. Interested small businesses and other eligible entities are encouraged to submit applications electronically by April 8, 2025, with the anticipated award date set for July 1, 2025. For further inquiries, applicants may contact Armineh Ghazarian at Armineh.Ghazarian@hhs.gov or by phone at 240-453-8200.
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) is inviting applications for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting projects that develop innovative technologies to enhance biomedical research capabilities. Eligible applicants include a diverse range of institutions such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that have demonstrated proof of principle but still face significant technical challenges. This initiative emphasizes the development of laboratory instruments, algorithms, and biological systems, while applications targeting specific biomedical questions will not be funded. Interested parties should note that the application deadline is May 7, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries. More details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-127.html.
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)" aimed at advancing innovative research into the biological factors that influence individual responses to probiotics. This initiative seeks applications that will explore person-specific characteristics, such as genetics, microbiome composition, and lifestyle, to improve the effectiveness of probiotic interventions and address variability in human responses. The total project period is limited to four years, with a maximum budget of $350,000 in direct costs per year, and applications are expected to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity. Interested applicants can find more information and submission guidelines at the NIH website, with the application deadline set for June 2, 2027, and anticipated awards starting in June 2025. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has announced a funding opportunity titled "Miniaturization and Automation of Tissue Chip Systems (MATChS)" aimed at supporting Small Business Technology Transfer (STTR) applications. This initiative seeks to enhance microphysiological systems that replicate organ functions, focusing on the development of compact, automated systems for real-time analysis of tissue health to improve drug discovery and precision medicine. Eligible U.S.-based small businesses can apply for funding of up to $2.15 million for Phase I and Phase II awards, with proposals required to demonstrate innovation, a clear commercialization strategy, and collaboration with NIH staff. Interested applicants should refer to the full announcement available at NIH Grants and note that the application deadline is February 23, 2026.